YEE LEE: Open Payments
NPI 1346024767 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,395 in 61 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,395
Food & beverage: $2,395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $709 |
| Madrigal Pharmaceuticals | 4 | $434 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $261 |
| Ardelyx, Inc. | 19 | $252 |
| GENZYME CORPORATION | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $92 |
| ORPHALAN INC | 2 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
Products named: REZDIFFRA, RINVOQ, XIFAXAN, IBSRELA, LINZESS, DUPIXENT, MAVYRET, TREMFYA.
Industry payments across CA — which companies pay providers there.
